Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

IBB vs ILF: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, IBB returned +37.5% to ILF's +17.2%, and IBB charges 0.44% to ILF's 0.47%.

askIQ about this page

askIQ about IBB and ILF

Net assets: $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF, and $3.5bn on Oct 28, 2026 for iShares Latin America 40 ETF.

At a glance
+37.5%
IBB total return, 1 year
+17.2%
ILF total return, 1 year
0.44%
IBB expense ratio
0.47%
ILF expense ratio

Pair scorecard

IBB costs 0.03 points a year less; their one-year returns differ by 20.3 points; IBB is 3.1 times larger.

IBB vs ILF: Differences, Returns & Fees
MeasureIBBILF
Return
Total return, 1 year+37.5%+17.2%
Drawdown
Below its high13.7%, high on Oct 12, 2026
Benchmark
What it tracksBiotechS&P Latin America 40
Cost and size
Expense ratio0.44%0.47%
Net assets, as of Oct 27, 2026$11.0bn$3.5bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
Top ten holdings, share of the fund50%55.6%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, IBB and ILF hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first IBB ILF
Only in one fund ↓
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Only in ILF
NU HOLDINGS CLASS A 7.53%
PETROLEO BRASILEIRO ADR REPTG PRE 6.95%
ITAU UNIBANCO HOLDING ADR REP PRE 6.61%
PETROLEO BRASILEIRO ADR REPTG SA 6.61%
VALE ADR REPRESENTING ONE 6.45%
GRUPO MEXICO B 6.26%
GPO FINANCE BANORTE 4.48%
CREDICORP LTD 3.96%
Check overlap with more funds →

Side by side

IBB iShares Biotechnology ETF ILF iShares Latin America 40 ETF
Where it sits Thematic ETF Stock ETF
What it is Biotech Tracks an index of Latin America 40
Total return, 1 year +37.5% +17.2%
Expense ratio 0.44% 0.47%
Already in the S&P 500 40.2% 0.0%
Holdings 245 46
Net assets, IBB as of Oct 27, 2026 and ILF as of Oct 28, 2026 $11.0bn $3.5bn

IBB and ILF on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

IBB and ILF flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

ILF

ILF tracks an index of Latin America 40. Over the year to Oct 28, 2026 it returned +17.2% with distributions reinvested. The prospectus expense ratio is 0.47% a year. By its holdings published by its issuer for Oct 27, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 46 positions, with the top ten at 55.6%. It sat 13.7% below its high of Oct 12, 2026 on Oct 28, 2026.

Questions people ask

Are IBB and ILF in the same category?
IBB is a thematic ETF and ILF is a stock ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IBB or ILF?
In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and ILF +17.2%.
Which is cheaper, IBB or ILF?
IBB is cheaper, by 0.03 percentage points a year. That is about $3 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do IBB and ILF overlap with the S&P 500?
By their latest filed holdings, 40% of IBB and 0% of ILF by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, IBB against ILF, data as of Oct 28, 2026. https://etfiq.com/compare/any/ibb-vs-ilf

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.